VDAC1 and noise induced hearing loss: In conclusion, this study showed that VDAC1 is involved in NIHL and demonstrated the therapeutic potential of DIDS, a VDAC1 inhibitor, in its prevention and treatment by alleviating oxidative stress and inflammation in HCs.